Patent ID: 7763605

Claim:
A compound of Formula (I): wherein: R 1 is independently selected from the group consisting of hydrogen, C 1-6 alkyl, C 1-6 alkoxy, and one to three halogen atoms; R 2 is independently selected from the group consisting of hydrogen, C 1-6 alkyl, aryl(C 1-6 )alkyl, cycloalkyl(C 1-6 )alkyl, (C 1-6 )alkylsulfonyl, arylsulfonyl, and C 1-6 alkylcarbonyl; G is independently selected from the group consisting of C 1-8 alkyl, C 1-8 alkoxy, C 3-10 cycloalkoxy, C 1-8 alkylcarbonyloxy, hydroxy, heterocyclyl, C 1-6 alkylthio, C 1-6 alkylsulfonyloxy, arylsulfonyloxy, and NR a R b ; R a and R b are independently selected from the group consisting of hydrogen and C 1-6 alkyl; or, R a and R b are taken with the nitrogen atom to which they are both attached form a 3 to 7 membered monocyclic heterocycle; provided that when R 2 is hydrogen or C 1-6 alkyl, G is other than C 1-8 alkyl, C 1-8 alkoxy, hydroxy, C 1-6 alkylsulfonyloxy, C 1-8 alkylcarbonyloxy, or NR a R b ; such that R a and R b are not taken together to form a heterocycle; X is independently selected from the group consisting of hydrogen, C 1-6 alkyl, C 1-6 alkoxy, and halogen; Z is one to three substituents independently selected from the group consisting of C 1-6 alkyl, C 1-6 alkoxy, C 1-6 alkylthio, halogen, hydroxy, nitro, and aryl, wherein said aryl is optionally substituted with one to five substituents independently selected from the group consisting of C 1-6 alkyl, C 1-6 alkoxy, hydroxy, C 1-6 alkylthio, and halogen; and wherein the C 1-6 alkyl and C 1-6 alkoxy substituents of Z are optionally fluorinated with one to thirteen fluorine atoms; and pharmaceutically acceptable enantiomers, diastereomers, racemates, and salts thereof.